Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LORMETAZEPAM vs LOVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LORMETAZEPAM vs LOVASTATIN: Safety Overview

Metric LORMETAZEPAM LOVASTATIN
Total FAERS Reports 3,074 1,387
Deaths Reported 384 204
Death Rate 12.5% 14.7%
Hospitalizations 1,763 287
Average Patient Age 54.2 yrs 60.2 yrs
% Female Patients 60.0% 55.9%
FDA Approval Date N/A Apr 14, 2006
Manufacturer N/A Preferred Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued